In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.
Related
Coffee Chat: John Carroll, Acosta Group
How Connected Commerce Can Reignite Growth with John Carroll, President of Connected Commerce at Acosta Group.
Video Forum: Dave Warner, KPH Healthcare Services
Kinney Drugs parent finds strength in diversification.
Video Forum: Ellen Kelsay, Business Group on Health
Examining health care through the lens of employers.
Latest
CRN opposes California protein powder bill
According to CRN, SB 1033 adopts misguided policies that impose burdens beyond federal rules and send alarmist messages about nonexistent harms.
FMI releases statement on January CPI food price numbers
“The food industry remains committed to keeping prices as low as possible for households across the country.”
Fresh Thyme Market reaffirms 2026 focus on health, hunger relief, and affordability
The grocer is extending key partnerships, reaffirming the commitment to invest in the well-being of the communities it serves
Save A Lot shows biggest customer satisfaction gain in recent national study
Save A Lot’s score jumped 4% to 78, marking the biggest gain in the supermarket sector year over year